Retinal ganglion cells death in glaucoma - Mechanism and potential treatment. Part II;Śmierć komórek zwojowych siatkówki w przebiegu jaskry - Patomechanizm i potencjalne możliwości leczenia. Czȩść II

Klinika Oczna

Volumn 109, Issue 7-9, 2007, Pages 353-355

  Rokicki, Wojciech ^b,c   Dorecka, Mariola ^a   Romaniuk, Wanda ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Wojewódzkiego Szpitala Specjalistycznego nr 5 Im w Barbary   (Poland)

^c Wojewódzki Szpital Specjalistyczny nr 5 Im Sw Barbary   (Poland)

Author keywords

Apoptosis; Glaucoma; Neuroprotection; Retinal ganglion cell

Indexed keywords

NEUROPROTECTIVE AGENT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL; CELL DEATH; CYTOLOGY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; ISCHEMIA; METABOLISM; OPTIC DISK; OPTIC NERVE DISEASE; PATHOLOGY; RETINA; RETINA GANGLION CELL; REVIEW;

ANIMALS; CELL DEATH; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; ISCHEMIA; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; OPTIC DISK; OPTIC NERVE DISEASES; REACTIVE OXYGEN SPECIES; RETINA; RETINAL GANGLION CELLS;

EID: 35349004851     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Neal MJ, Cunningham JR, Hutson PH, Hogg J.: Effects of ischaemia on neurotransmitter release from the isolated retina. J Neurochem 1994, 62, 1025-1033.
2. Siliprandi R, Canella R, Carmignoto G, Schiavo N, Zanellato A, Zanoni R, Vantini G: N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992, 8, 567-573.
3. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA.: Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996, 114, 299-305.
4. Honkanen RA, Baruah S, Zimmerman MB, Khanna CL, Weaver YK, Narkiewicz J, Waziri R, Gehrs KM, Weingeist TA, Boldt HC, Folk JC, Russell SR, Kwon YH: Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch Ophthalmol. 2003 Feb, 121, 183-188.
5. Ullian EM, Barkis WB, Chen S, Diamond JS, Barres BA: Invulnerability of retinal ganglion cells to NMDA excitotoxicity. Mol Cell Neurosci. 2004, 26, 544-557.
6. Hare WA, WoldeMussie E, Lai RK, Ton H, Ruiz G, Chun T, Wheeler L.: Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey. I: Functional measures. Invest Ophthalmol Vis Sci 2004, 45, 2625-2639.
7. Hare WA, WoldeMussie E, Weinreb RN, Ton H, Ruiz G, Wijono M, Feldmann B, Zangwill L, Wheeler L.: Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey. II: Structural measures. Invest Ophthalmol Vis Sci 2004, 45, 2640-2651.
8. Netland PA, Chaturvedi N, Dreyer EB: Calcium channel blockers in the management of low tension and open angle glaucoma. Am J Ophthalmol 1993, 115, 608-613.
9. Eschweiler GW, Bahr M: Flunarizine enhances rat retinal ganglion cell survival after axotomy. J Neurol Sci 1993, 116, 34-40.
10. Kuriyama H, Waki M, Nakagawa M, Tsuda M: Involvement of oxygen free radicals in experimental retinal ischemia and the selective vulnerability of retinal damage. Ophthalmic Res. 2001, 33, 196-202.
11. Tezel G, Yang X: Caspase-independent component of retinal ganglion cell death, in vitro. Invest Ophthalmol Vis Sci. 2004, 45, 4049-4059.
12. Neufeld AH: Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res Bull. 2004, 62, 455-459.
13. Neufeld AH, Das S, Vora S, Gachie E, Kawai S, Manning PT, Connor JR.: A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma. J Glaucoma 2002, 11, 221-225.
14. Wax MB.: Is there a role for the immune system in glaucomatous optic neuropathy? Curr Opin Ophthalmol 2000, 11, 145-150.
15. Kipnis J, Yoles E, Porat Z, Cohen A, Mor F, Sela M, Cohen IR, Schwartz M: T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci USA. 2000, 97, 7446-7451.